4BB logo

4basebio Share Price

Symbol: AIM:4BBMarket Cap: UK£149.4mCategory: Pharmaceuticals & Biotech

4BB Share Price Performance

4BB Community Fair Values

    Recent 4BB News & Updates

    No updates

    4basebio PLC Key Details

    UK£933.0k

    Revenue

    UK£303.0k

    Cost of Revenue

    UK£630.0k

    Gross Profit

    UK£13.0m

    Other Expenses

    -UK£12.3m

    Earnings

    Last Reported Earnings
    Dec 31, 2024
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.80
    Gross Margin
    67.52%
    Net Profit Margin
    -1,321.87%
    Debt/Equity Ratio
    54.7%

    4basebio PLC Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 4BB

    Founded
    2008
    Employees
    110
    CEO
    Heikki Lanckriet
    WebsiteView website
    www.4basebio.com

    4basebio PLC, together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally. The company offers hpDNA, double stranded linear DNA, covalently closed with single strand hairpins at the 5’ and 3’ ends for viral and non-viral vector applications; opDNA, a partially opened, linear, double stranded DNA product for in vitro transcription processes for the production of mRNA for use in vaccines and therapeutics; and oeDNA, or open ended DNA, a linear, double stranded DNA product ideal for genome editing. It also provides osDNA, or open stabilized DNA, a product incorporating nucleotide modifications within the DNA backbone enables tuning of the immunostimulatory properties of the construct for DNA vaccine applications; and The Hermes, a proprietary delivery platform for nucleic acid and protein payloads appears to offer a thermo-stable alternative to traditional lipid based delivery systems. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.

    U.K. Market Performance

    • 7 Days: 1.6%
    • 3 Months: 7.6%
    • 1 Year: 7.9%
    • Year to Date: 8.1%
    Over the last 7 days, the market has risen 1.1%, driven by gains of 5.3% in the Materials sector. As for the past 12 months, the market is up 7.4%. Earnings are forecast to grow by 15% annually. Market details ›
    The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
    Continue reading